Allmax Berberine HCL 30 Capsules
Allmax Berberine HCL 30 Capsules
Allmax Berberine HCL taps into the potent power of a naturally-occurring plant extract renowned for its metabolic benefits. This supplement is formulated with Berberine HCL, the most studied form, to enhance glycogen storage and support healthy digestion. Clinical studies have demonstrated that Allmax Berberine HCL helps promote healthy blood sugar metabolism, supports weight maintenance, boosts immune function, and contributes to a balanced gut microbiome, all while helping to maintain healthy cholesterol levels. This makes it an essential supplement for those seeking comprehensive metabolic support.
Allmax Berberine HCL 30 Capsules Highlights & Benefits
- Best Known for Helping Manage Blood Sugar & Improving Insulin Sensitivity
- May Help Reduce Cholesterol
- Berberine Has Anti-Inflammatory & Antioxidant Effects
- Supports Weight Management
- Vegan Friendly
Is Berberine Bad For Your Kidneys or Liver?
Berberine has been reported to potentially affect kidney function in individuals with pre-existing kidney disease. Berberine can be metabolized by the liver and excreted by the kidneys which may put added stress on these organs. Berberine may also interact with various medications which are metabolized by the liver. People with pre-existing kidney, liver or renal issues may want to avoid Berberine supplements or should contact a healthcare provider before starting Berberine or any new supplement.
Directions
Take 1-2 capsules daily.
Allmax Berberine HCL 30 Capsules Ingredients
Serving Size: 1 Capsule
Servings Per Container: 30
Amount Per Serving % Daily Value
Berberine HCL (Berberis aristata, bark) (90% Active Berberine) 500 mg
Other Ingredients: Vegan caps (Hypromellose), Microcrystalline cellulose, Magnesium stearate.
Warnings & Side Effects
Store in a cool dry place after opening.
References
Ai X, Yu P, Peng L, Luo L, Liu J, Li S, Lai X, Luan F, Meng X. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases. Front Pharmacol. 2021 Nov 3;12:762654. doi: 10.3389/fphar.2021.762654. PMID: 35370628; PMCID: PMC8964367.
